Correlation Between Carsales and Syndax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Carsales and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Carsales and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Carsales and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Carsales and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Carsales with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Carsales and Syndax Pharmaceuticals.
Diversification Opportunities for Carsales and Syndax Pharmaceuticals
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Carsales and Syndax is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Carsales and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Carsales is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Carsales are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Carsales i.e., Carsales and Syndax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Carsales and Syndax Pharmaceuticals
Assuming the 90 days trading horizon Carsales is expected to generate 0.31 times more return on investment than Syndax Pharmaceuticals. However, Carsales is 3.2 times less risky than Syndax Pharmaceuticals. It trades about -0.39 of its potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about -0.18 per unit of risk. If you would invest 2,540 in Carsales on September 20, 2024 and sell it today you would lose (240.00) from holding Carsales or give up 9.45% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Carsales vs. Syndax Pharmaceuticals
Performance |
Timeline |
Carsales |
Syndax Pharmaceuticals |
Carsales and Syndax Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Carsales and Syndax Pharmaceuticals
The main advantage of trading using opposite Carsales and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Carsales position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.The idea behind Carsales and Syndax Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Syndax Pharmaceuticals vs. SAFETY MEDICAL PROD | Syndax Pharmaceuticals vs. ACCSYS TECHPLC EO | Syndax Pharmaceuticals vs. Apollo Medical Holdings | Syndax Pharmaceuticals vs. Japan Medical Dynamic |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |